• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of Y-cetuximab: A preclinical trial" by A Dietrich et al.

作者信息

Dietrich Antje, Andreeff Michael, Koi Lydia, Bergmann Ralf, Schubert Maik, Schreiner Lena, Löck Steffen, Sihver Wiebke, Freudenberg Robert, Hering Sandra, Pietzsch Hans-Jürgen, Steinbach Jörg, Kotzerke Jörg, Baumann Michael, Krause Mechthild

机构信息

German Cancer Consortium (DKTK), Partner Site Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, Germany.

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU, Dresden, Germany.

出版信息

Radiother Oncol. 2021 Aug;161:261-262. doi: 10.1016/j.radonc.2021.06.014. Epub 2021 Jun 11.

DOI:10.1016/j.radonc.2021.06.014
PMID:34119587
Abstract
摘要

相似文献

1
In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of Y-cetuximab: A preclinical trial" by A Dietrich et al.针对陈和刘致编辑的信，信的内容是关于A·迪特里希等人的“放射治疗增强Y-西妥昔单抗的摄取和疗效：一项临床前试验”。
Radiother Oncol. 2021 Aug;161:261-262. doi: 10.1016/j.radonc.2021.06.014. Epub 2021 Jun 11.
2
Letter to the editor of radiotherapy and oncology regarding of the paper "Radiotherapy enhances uptake and efficacy of Y-cetuximab: A preclinical trial" by A Dietrich et al.
Radiother Oncol. 2021 Aug;161:260. doi: 10.1016/j.radonc.2021.06.013. Epub 2021 Jun 10.
3
Radiotherapy enhances uptake and efficacy of Y-cetuximab: A preclinical trial.放疗增强 Y-西妥昔单抗摄取和疗效：一项临床前试验。
Radiother Oncol. 2021 Feb;155:285-292. doi: 10.1016/j.radonc.2020.11.013. Epub 2020 Nov 21.
4
In reply to the letter to the editor: "In reply to Fiorino et al: The central role of the radiation oncologist in the multidisciplinary and multiprofessional model of modern radiation therapy".
Radiother Oncol. 2021 Feb;155:e22-e23. doi: 10.1016/j.radonc.2020.12.033. Epub 2021 Jan 4.
5
Letter to the editor of radiotherapy and oncology regarding the article esposito et al: Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods.致《放射治疗与肿瘤学》编辑的信，关于埃斯波西托等人的文章：立体定向体部放射治疗中剂量传递准确性的评估：体内测量方法综述
Radiother Oncol. 2020 Dec;153:319. doi: 10.1016/j.radonc.2020.06.047. Epub 2020 Jul 9.
6
Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, Volume 165).
Radiother Oncol. 2022 Jul;172:149-150. doi: 10.1016/j.radonc.2022.04.002. Epub 2022 Apr 9.
7
Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, volume 165).
Radiother Oncol. 2022 Jul;172:151-152. doi: 10.1016/j.radonc.2022.04.001. Epub 2022 Apr 7.
8
Response to the letter to the editor by Macià i Garau et al. regarding the article "ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma" by Niyazi et al.对Macià i Garau等人致编辑的信的回复，该信是关于Niyazi等人的文章《欧洲放射肿瘤学会-欧洲神经肿瘤协会胶质母细胞瘤靶区勾画和放疗细节指南》
Radiother Oncol. 2024 Jan;190:109965. doi: 10.1016/j.radonc.2023.109965. Epub 2023 Nov 3.
9
Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.致《放射治疗与肿瘤学》编辑的信，关于维亚等人所著题为《用于改善眼部质子治疗中眼生物测量的MRI与眼底图像融合》的论文
Radiother Oncol. 2022 Nov;176:251. doi: 10.1016/j.radonc.2022.08.018. Epub 2022 Aug 18.
10
Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".对《致〈放射治疗与肿瘤学〉编辑的信》的回复，该信是关于Via等人发表的题为《MRI与眼底图像融合用于改善眼部质子治疗中的眼生物测量》的论文。
Radiother Oncol. 2022 Nov;176:252. doi: 10.1016/j.radonc.2022.08.017. Epub 2022 Aug 18.